Department of Internal Medicine

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Stents Medicine & Life Sciences

Korea Medicine & Life Sciences

Therapeutics Medicine & Life Sciences

Stomach Neoplasms Medicine & Life Sciences

Hepatocellular Carcinoma Medicine & Life Sciences

Atrial Fibrillation Medicine & Life Sciences

Drug-Eluting Stents Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

SangHoon Ahn

AHNSH@YUHS.AC

Department of Internal Medicine

Person: Academic

Hyuk-Jae Chang

HJCHANG@YUHS.AC

Department of Internal Medicine

Person: Academic

JaeHee Cheon

GENIUSHEE@YUHS.AC

Department of Internal Medicine

Person: Academic

Research Output 1981 2019

5629 Article
241 Review article
113 Letter
99 Comment/debate
99 More

Accessory pathway-related left ventricular wall motion abnormality and the effects of radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome

Uhm, J. S., Nam, J. H., Yu, H. T., Yang, P. S., Kim, T. H., Cho, I. J., Shim, C., Joung, B., Hong, G. R., pak, H. & Lee, M. H., 2019 Jan 1, In : Journal of Cardiovascular Electrophysiology. 30, 1, p. 102-108 7 p.

Research output: Contribution to journal › Article

Catheter Ablation

Dyskinesias

Wolff-Parkinson-White Syndrome

Patient Rights

Odds Ratio

Antithrombotic medication and the risk of vitreous hemorrhage in atrial fibrillation: Korean national health insurance service national cohort

Kim, K. E., Yang, P. S., Jang, E., Kim, S. & Joung, B., 2019 Jan 1, In : Yonsei medical journal. 60, 1, p. 65-72 8 p.

Research output: Contribution to journal › Article

Vitreous Hemorrhage

National Health Programs

Warfarin

Atrial Fibrillation

Platelet Aggregation Inhibitors

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Bang, Y. J., Kang, Y. K., Ng, M., Chung, H., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., 2019 Feb 1, In : European Journal of Cancer. 108, p. 17-24 8 p.

Research output: Contribution to journal › Article

Esophagogastric Junction

Stomach

Disease-Free Survival

Placebos

Neoplasms